Home Blog Page 173

Blog

Pharma Marketing Blog

Latest

What’s Your Opinion of PhRMA’s New Code?

Pharma Guy - July 10, 2008

Pharma Vendor and Ad Agency Diversity: All Talk, No Action?

Pharma Guy - July 9, 2008

A Novel Approach to Communicating with Physicians

Pharma Guy - July 8, 2008

AAP Guidelines May Help Extend the Patent Life of Lipitor

Pharma Guy - July 7, 2008

FDA Intern vs. Inebriated Advisory Committee Antagonist

Pharma Guy - July 2, 2008

If Doctors, Like Nascar Drivers, Wore Their Sponsors’ Logos

Pharma Guy - July 1, 2008

New alli Plan to Gain Market Share: Eliminate the Competition!

Pharma Guy - July 1, 2008

40over40: Lilly’s DTC ED Awareness Campaign in the UK

Pharma Guy - July 1, 2008

I Opt-Out of My alli Challenge!

Pharma Guy - June 30, 2008

Marketing Mix of Leading Pharma Advertisers

Pharma Guy - June 30, 2008

1...172173174...241 Page 173 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Split image showing a stopwatch symbolizing speed and a compliance checklist with medical tools representing safety in pharma marketing

Speed vs Safety: How Pharma Marketers Can Compete in a Faster,...

April 23, 2026

Balance scale comparing pharmaceutical demand and clinical evidence with GLP-1 medications and research materials

The Demand–Evidence Gap: What GLP-1 Growth Teaches Pharma Marketers About Responsible...

April 22, 2026

Pharmaceutical professional using AI-driven tools to optimize healthcare content with digital brain interface and data analytics

The Algorithmic Gatekeeper: How Pharma Marketers Can Stay Visible in AI-Filtered...

April 20, 2026